In the published article, there was an error in Table 1 as published. The information about the smoking history (Stop Smoking) for the subjects with ‘No COPD’ was duplicated. The corrected Table 1 and its caption appear below.
Table 1
| No COPD | Mild COPD | Severe COPD | |
|---|---|---|---|
| Age* | 54.2 ± 3.2 | 69.2 ± 3.9 | 65.1 ± 2.7 |
| Gender, M/F | 3M/3F | 4M/2F | 3M/5F |
| Smoking in PY* | 54.0 ± 12.6 (2) | 29.9 ± 10.7 (3) | 35.0 ± 2.8 (3) |
| Stop Smoking (Y)* | 6.6 ± 1.6 | 21.4 ± 12.8 | 11.9 ± 2.5 |
Demographics of the study cohort of COPD patients with clinically-defined GOLD stage severity and self-reported smoking history.
*Mean, ± SEM; M, Male; F, Female; PY, Packs per Year; Y, Years.
The authors state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
bronchial epithelial cells, cigarette smoke (CS), chronic obstructive pulmonary disease (COPD), long noncoding RNA (lncRNA), mucus hyperexpression, lncRNA antisense to ICAM-1 (LASI)
Citation
Manevski M, Devadoss D, Long C, Singh SP, Nasser MW, Borchert GM, Nair MN, Rahman I, Sopori M and Chand HS (2022) Corrigendum: Increased expression of LASI LncRNA regulates the cigarette smoke and COPD associated airway inflammation and mucous cell hyperplasia. Front. Immunol. 13:988069. doi: 10.3389/fimmu.2022.988069
Received
06 July 2022
Accepted
25 July 2022
Published
08 August 2022
Volume
13 - 2022
Edited and reviewed by
Nils Yngve Lycke, University of Gothenburg, Sweden
Updates
Copyright
© 2022 Manevski, Devadoss, Long, Singh, Nasser, Borchert, Nair, Rahman, Sopori and Chand.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Hitendra S. Chand, hchand@fiu.edu
This article was submitted to Mucosal Immunity, a section of the journal Frontiers in Immunology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.